Skip to main content
. 2022 May 24;99(4):723–732. doi: 10.1007/s11524-022-00647-1

Table 2.

CONNECT participants experience with and attitudes towards drug use, OPS, and other harm reduction interventions stratified by OPS support in Baltimore, Maryland (N = 135)

Total Support OPS in neighborhood p-value
(N = 135) No (n = 47; 35%) Yes (n = 88; 65%)
Col % Row % Row %
Attitudes towards people who use drugs
  Should be arrested 60 (44.4) 26 (43.3) 34 (56.7) 0.063
  Are dangerous 77 (57.0) 36 (46.8) 41 (53.2) 0.001
  Deserve respect 107 (79.3) 37 (34.6) 70 (65.4) 0.911
  Deserve access to treatment 129 (95.6) 42 (32.6) 87 (67.4) 0.011
Workplace exposures
  Some or all people entering the business use drugs 122 (91.7) 41 (33.6) 81 (66.4) 0.195
  Perceived drugs commonly used around workplace+
  Opioids (fentanyl, heroin, pills) 107 (84.3) 30 (28.0) 77 (72.0) 0.018
  Stimulants (cocaine, crack cocaine, crystal methamphetamine) 98 (77.2) 29 (29.6) 69 (70.4) 0.233
Workplace drug exposure scale components +
  Found drugs 63 (48.1) 19 (30.2) 44 (69.8) 0.331
  Found drug paraphernalia 65 (49.6) 21 (32.3) 44 (67.7) 0.625
  Seen drug use 87 (66.4) 26 (29.9) 61 (70.1) 0.130
  Seen drug dealing 90 (68.7) 30 (33.3) 60 (66.7) 0.716
  Asked somebody to leave or banned them due to drug use 82 (61.2) 26 (31.7) 56 (68.3) 0.305
  Called 911 due to drug use or overdose 46 (34.3) 15 (32.6) 31 (67.4) 0.665
Witnessed an overdose in or around business+ 61 (46.6) 15 (24.6) 46 (75.4) 0.024
Exposure to harm reduction interventions
  Heard of naloxone 94 (69.6) 28 (29.8) 66 (70.2) 0.063
  Had naloxone in business 35 (37.6) 8 (22.9) 27 (77.1) 0.255
  Any employees trained to administer naloxone 44 (48.9) 10 (22.7) 34 (77.3) 0.171
  Ever administered naloxone 10 (7.6) 2 (20.0) 8 (80.0) 0.493
  Heard of OPS before this study 56 (41.5) 15 (26.8) 41 (73.2) 0.142

+past 6 months